Navigation Links
Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
Date:12/16/2008

SEATTLE, Dec. 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.(CTI) (Nasdaq and MTA: CTIC) announced today they have closed the transaction with Spectrum Pharmaceuticals, Inc. to form a 50/50 owned joint venture, RIT Oncology LLC (LLC), to commercialize and develop Zevalin(R) ([90Y]-ibritumomab tiuxetan) in the United States. In connection with the closing, Cell Therapeutics received an initial payment of $7.5 million and will receive an additional $7.5 million in early January. The Company may earn an additional $15 million in product sales milestone payments upon achievement of certain revenue targets.

"RIT Oncology is the first business venture focused on the advancement of radioimmunotherapy (RIT) in the treatment of lymphoma which provides significant resources to help accomplish that mission," said James A. Bianco, M.D., CEO of Cell Therapeutics, Inc. "RIT like Zevalin has been underutilized since its introduction in 2002. With the potential for a first-line indication for consolidation of remission in patients with follicular non-Hodgkin's lymphoma, we will be uniquely positioned to maximize physician and patient access with this potentially valuable treatment option."

Zevalin, a radioimmunotherapeutic, has been exclusively marketed by CTI in the United States since December, 2007 and will now be marketed jointly by CTI and Spectrum through the LLC for the treatment of patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL), including patients who have rituximab-refractory follicular NHL. The U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, a supplemental Biologics License Application (sBLA) filed by CTI for use of Zevalin as consolidation therapy for patients with follicular B-cell non-Hodgkin's lymphoma who achieve a response to first-line therapy. A Prescription Drug User Fee Act (
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
2. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
3. Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
4. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
5. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints
6. Transition Therapeutics Announces Dates for Upcoming Corporate Events
7. Taligen Therapeutics Advances Corporate Growth Plan with Appointment of Jeffrey T. Walsh as Chief Business Officer
8. Precision Therapeutics Secures $43 Million in Venture Capital Funding
9. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
10. Hyperion Therapeutics Completes Phase 2 Data Analysis and Schedules End of Phase 2 Meeting With FDA for HPN-100 in the Chronic Treatment of Urea Cycle Disorders
11. Transition Therapeutics Announces First Quarter Fiscal 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... York, NY (PRWEB) December 21, 2014 ... nearing 1,400 in a consolidated litigation underway in New ... documents, a total of 1,375 claims involving the birth ... Superior Court. These lawsuits were filed by women who ... to have led to uterine perforations and other complications ...
(Date:12/21/2014)... AlignLife of Norton Shores is spreading Christmas ... time helping people get their health back. Mission for ... serving those persons in Muskegon County who are unable to ... of life. Dr. Michael Rykse wanted to do a Toy ... and he knew he found that when he heard what ...
(Date:12/21/2014)... San Francisco, California (PRWEB) December 21, 2014 ... announces his search for Vintage 1967 Jm Morrison and the ... D.C. concert posters. This would also be the only ... live. The concert was on Nov. 25, 1967. According ... in Washington D.C. They did play the Alexandria Roller ...
(Date:12/21/2014)... 21, 2014 Parker & Sons, Inc. ... cooling, plumbing and other similar home contractor services announces ... regard to its expert contracting services. The company is ... has been serving Arizona for well over 40 years. ... absolute best in quality customer service to the residents ...
(Date:12/21/2014)... December 21, 2014 Over the past ... issues in hundreds of emergency departments across the nation, ... findings have been translated into an innovative suite of ... correct deficiencies and enhance the patient experience. , ... physician staffing and management services for hospitals, announced the ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2
... has been selected for the Physician of the Year Award by ... surgeon director in Otolaryngology at the same Infirmary, will be presented ... Nov 20 in New York., ,Mehta graduated in medicine from ... He has been affiliated with the Infirmary for more than 25 ...
... 50 percent of the clan is found battling chronic skin ... new study has claimed that nearly 50,000 hair stylists are ... shampoos that render constantly moist hands., ,Due to this, ... on with their jobs when the condition worsens. Hairdressers are ...
... more salt than the deep blue sea, according to a ... brings about a dramatic reduction in their blood pressure which ... disease and stroke later in life. ,The report states ... Twirls contain more than twice as much salt as the ...
... that although very difficult to disseminate actual figures it ... of the funds allocated for the disbursement of medicines ... or lost because of fraudulent practices, bribery and diversion ... assessed that governments spent about US$50 billion (€39 billion) ...
... killer H5N1 avian flu virus that had emerged in early ... resistant to the vaccination programme and might even be aided ... wave of transmission of H5N1 avian flu and could potentially ... of the Proceedings of National Academy of Sciences. ,The ...
... regularly, because the size of your paunch is directly related ... new research conducted by a medical expert of Indian origin. ... University of Leicester, obesity has now become a worldwide epidemic. ... currently over half of women and two-thirds of men in ...
Cached Medicine News:Health News:Hair-raising issues of hairdressers 2Health News:Kids' Food: Saltier than the Deep Blue Sea 2Health News:Kids' Food: Saltier than the Deep Blue Sea 3Health News:Kids' Food: Saltier than the Deep Blue Sea 4
(Date:12/17/2014)... December 17, 2014 Revenue and earnings ... on research and development In the past 2013/14 ... by two percent to EUR 4.287 billion (last year: EUR ... 14 percent to EUR 360 million. "Overall, 2013/14 was a ... Michael Kaschke , President and CEO of Carl Zeiss AG. ...
(Date:12/17/2014)... Dec. 17, 2014 With advancements in ... MRI market is seeing new growth, according to ... scans account for the majority of market volume, ... of images, which are creating opportunities for more sophisticated ... is growing at a rate of 4%, with ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... dimeglumine) is a paramagnetic MRI contrast agent. ... gadobenate, a chelating agent that forms a ... ion. It is salified with meglumine forming ... all the physico-chemical features typical of gadolinium ...
... OMNISCAN was launched in the U.S. ... the central nervous system (CNS) to detect ... associated tissues. OMNISCAN has since received approval ... and pediatric CNS and body indications. OMNISCAN ...
... dimeglumine) injection was introduced in 1988, it ... magnetic resonance imaging (MRI). It became the ... MRI. Today, the product is still a ... neck and body. MAGNEVIST is used in ...
... in 1996, VISIPAQUE is the only isosmolar contrast ... osmolality equal to that of blood, VISIPAQUE was ... also the only contrast medium formulated with sodium ... In 1997, VISIPAQUE received FDA approval for use ...
Medicine Products: